External quality assessment in haematology: an update
Barbara Wild and colleagues from UK NEQAS Haematology examine the responses to a recent abnormal haemoglobin distribution, and also discuss findings from the Liquid Newborn Specimens Scheme.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide...